New

Conduit Pharmaceuticals Announces Advancements in Lupus Treatment Research

March 28, 2025

News

Lupus Foundation of America Announces LFA LIFT to Accelerate Development of New Lupus Treatments

March 27, 2025

News

New

New Study Identifies Potential Biomarkers for Predicting Effectiveness of Mesenchymal Stem Cell Transplantation Therapy in People with Systemic Lupus Erythematosus

March 24, 2025

News

New

Healthy Lifestyle Intervention Shows Promise for Individuals with Systemic Lupus Erythematosus

March 21, 2025

News

New

Highlights from the Systemic Lupus International Collaborating Clinics World Lupus Seminar on Africa

March 20, 2025

News

New Study Evaluates the Modified NIH Scoring System's Effectiveness in Predicting End-Stage Kidney Disease in Latin American People with Lupus Nephritis

March 11, 2025

News

New Study Highlights the Impact of Flares and Persistently Active Disease on Organ Damage in People with Systemic Lupus Erythematosus

March 6, 2025

News

FDA Accepts Supplemental Biologics License Application for Gayzva for Treatment of Lupus Nephritis

March 5, 2025

News

New Study Investigates the Role of microRNA-203 as a Potential Biomarker for Lupus Nephritis

February 28, 2025

News

Conduit Pharmaceuticals Partners with Charles River Laboratories to Evaluate AZD1656 for Lupus Treatment

February 24, 2025

News

LUPKYNIS® Continues to Show Favorable Outcomes for Lupus Nephritis Treatment

June 8, 2023

News

Dept. of Defense Announces Lupus Research Program's 2023 Funding Opportunities

May 3, 2023

News